{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:56:29Z","timestamp":1793094989611,"version":"4.5.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ejinme.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ejim.2024.04.006","type":"journal-article","created":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T04:11:23Z","timestamp":1713067883000},"page":"127-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The clinical spectrum of thymoma-associated immunodeficiency: Good syndrome and beyond"],"prefix":"10.1016","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4055-7391","authenticated-orcid":false,"given":"Chen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Rong","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolan E.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2024.04.006_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.679556","article-title":"When the good syndrome goes bad: a systematic literature review","volume":"12","author":"Shi","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejim.2024.04.006_bib0002","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJMoa2210665","article-title":"Anti-interleukin-23 autoantibodies in adult-onset immunodeficiency","volume":"390","author":"Cheng","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2024.04.006_bib0003","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejim.2022.11.021","article-title":"Non-infectious gastrointestinal manifestations of Good syndrome","volume":"109","author":"Wang","year":"2023","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2024.04.006_bib0004","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20091669","article-title":"Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines","volume":"207","author":"Kisand","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.ejim.2024.04.006_bib0005","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJMoa2302892","article-title":"Health consequences of thymus removal in adults","volume":"389","author":"Kooshesh","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2024.04.006_bib0006","doi-asserted-by":"crossref","first-page":"AB25","DOI":"10.1016\/j.jaci.2021.12.117","article-title":"Prevalence of anti-lymphocyte antibodies in patients with good syndrome and partial RAG deficiency","volume":"149","author":"Wang","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ejim.2024.04.006_bib0007","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/imr.12714","article-title":"Lessons from primary immunodeficiencies: autoimmune regulator and autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"287","author":"Constantine","year":"2019","journal-title":"Immunol Rev"},{"key":"10.1016\/j.ejim.2024.04.006_bib0008","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1172\/JCI91162","article-title":"Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency","volume":"126","author":"Walter","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejim.2024.04.006_bib0009","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202486","article-title":"Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine","volume":"218","author":"Bastard","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.ejim.2024.04.006_bib0010","article-title":"Unraveling the natural history of Good's syndrome: a progressive combined adult immunodeficiency","author":"Kabir","year":"2023","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524001602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524001602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T12:04:50Z","timestamp":1731067490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620524001602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":10,"alternative-id":["S0953620524001602"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2024.04.006","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical spectrum of thymoma-associated immunodeficiency: Good syndrome and beyond","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2024.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}]}}